(Q35540359)

8 August 2017

1 reference

title

Cerebrovascular risk factors in Alzheimer's disease: brain hemodynamics and pharmacogenomic implications (English)

1 reference

8 August 2017

Cerebrovascular risk factors in Alzheimer's disease: Brain hemodynamics and pharmacogenomic implications (English)

1 reference

https://api.crossref.org/works/10.1179/016164103101202002

12 March 2024

0 references

1 reference

1 reference

https://api.crossref.org/works/10.1179/016164103101202002

12 March 2024

1

Ramón Cacabelos

1 reference

8 August 2017

Lucía Fernández-Novoa

2

1 reference

8 August 2017

Valter Lombardi

3

1 reference

8 August 2017

Lola Corzo

4

1 reference

8 August 2017

Victor Pichel

5

1 reference

8 August 2017

Yasuhiko Kubota

6

1 reference

8 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14503010

12 March 2024

publication date

1 September 2003

1 reference

full work available at URL

8 August 2017

http://www.tandfonline.com/doi/pdf/10.1179/016164103101202002

1 reference

https://api.crossref.org/works/10.1179/016164103101202002

12 March 2024

published in

Neurological Research

1 reference

8 August 2017

25

1 reference

8 August 2017

567-580

1 reference

8 August 2017

6

1 reference

The effects of age on rate of progression of Alzheimer disease and dementia with associated cerebrovascular disease

8 August 2017

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202002

Mixed dementia--the most common cause of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202002

Pharmacogenomics in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202002

Pharmacogenomics for the treatment of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202002

Prevalence of dementia and dementing diseases in Japan: the Tajiri project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202002

Brain damage after coronary artery bypass grafting

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202002

Vascular risk factors for Alzheimer's disease: an epidemiologic perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202002

Alzheimer disease as a vascular disorder: nosological evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202002

Vascular basis of Alzheimer's pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202002

Serum cholesterol, APOE genotype, and the risk of Alzheimer's disease: a population-based study of African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202002

Caloric intake and the risk of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202002

Serum lipoprotein levels, statin use, and cognitive function in older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202002

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202002

Statins in the prevention and treatment of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202002

Role of the low-density lipoprotein receptor-related protein in beta-amyloid metabolism and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202002

Vascular disease and cognitive function in older men in the Caerphilly cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202002

White matter lesions, quantitative magnetic resonance imaging, and dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202002

Histamine function in brain disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202002

The nitration product 5-nitro-gamma-tocopherol is increased in the Alzheimer brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202002

Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202002

Beta-amyloid inhibits integrated mitochondrial respiration and key enzyme activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202002

Inducible nitric oxide synthase and argininosuccinate synthetase: co-induction in brain tissue of patients with Alzheimer's dementia and following stimulation with beta-amyloid 1-42 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202002

Proinflammatory effects of M-CSF and A beta in hippocampal organotypic cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202002

Role of nitric oxide in inflammation-mediated neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202002

Neurotoxic mechanisms triggered by Alzheimer's disease-linked mutant M146L presenilin 1: involvement of NO synthase via a novel pertussis toxin target

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202002

Apolipoprotein E and Alzheimer disease: an update on genetic and functional analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202002

Therapeutic effects of CDP-choline in Alzheimer's disease. Cognition, brain mapping, cerebrovascular hemodynamics, and immune factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202002

Progress in the development of selective nitric oxide synthase (NOS) inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202002

Evidence that Alzheimer's disease is a microvascular disorder: the role of constitutive nitric oxide

21 January 2018

12

1 reference

https://api.crossref.org/works/10.1179/016164103101202002

Outcome at 30 days in the New England Medical Center Posterior Circulation Registry

12 March 2024

13

1 reference

https://api.crossref.org/works/10.1179/016164103101202002

Peripheral Blood Abnormalities in Alzheimer Disease: Evidence for Early Endothelial Dysfunction

12 March 2024

31

1 reference

https://api.crossref.org/works/10.1179/016164103101202002

Peroxynitrite mediates neurotoxicity of amyloid beta-peptide1-42- and lipopolysaccharide-activated microglia.

12 March 2024

37

1 reference

https://api.crossref.org/works/10.1179/016164103101202002

Nitric oxide-releasing drugs: a novel class of effective and safe therapeutic agents

12 March 2024

38

1 reference

https://api.crossref.org/works/10.1179/016164103101202002

Microglial activation and beta -amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice.

12 March 2024

39

1 reference

https://api.crossref.org/works/10.1179/016164103101202002

12 March 2024

Identifiers

1 reference

8 August 2017

1 reference